Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Dettling

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Lancet (London, England)|April 14, 2009
Are new drugs for schizophrenia better than old ones?Ion Anghelescu, Michael Dettling
The New England Journal of Medicine|May 9, 2014
Variant GADL1 and response to lithium in bipolar I disorderIon Anghelescu, Michael Dettling
Psychiatrische Praxis|December 9, 2004
[Social psychiatry and schizophrenia--changes and perspectives]Michael Dettling, Manfred Schönhoff
JAMA|June 24, 2015
Housing for Homeless Adults With Mental IllnessMichael Dettling, Ion Anghelescu
JAMA|February 24, 2012
Neuron number in children with autismIon Anghelescu, Michael Dettling
Lancet (London, England)|December 9, 2014
Psychotropics and risk of violent crimeMichael Dettling, Ion Anghelescu
The New England Journal of Medicine|May 23, 2014
Pregabalin versus pramipexole for restless legs syndromeIon Anghelescu, Michael Dettling
The New England Journal of Medicine|February 28, 2009
Subthalamic nucleus stimulation in severe obsessive-compulsive disorderMichael Dettling, Ion-George Anghelescu
The New England Journal of Medicine|January 20, 2006
Antipsychotic drugs and schizophreniaMichael Dettling, Ion-George Anghelescu
Pharmacogenomics|August 7, 2008
Clozapine-induced agranulocytosis and its genetic determinantsCarolin Opgen-Rhein, Michael Dettling
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Lancet (London, England)|April 14, 2009
Are new drugs for schizophrenia better than old ones?Ion Anghelescu, Michael Dettling
The New England Journal of Medicine|May 9, 2014
Variant GADL1 and response to lithium in bipolar I disorderIon Anghelescu, Michael Dettling
Psychiatrische Praxis|December 9, 2004
[Social psychiatry and schizophrenia--changes and perspectives]Michael Dettling, Manfred Schönhoff
JAMA|June 24, 2015
Housing for Homeless Adults With Mental IllnessMichael Dettling, Ion Anghelescu
JAMA|February 24, 2012
Neuron number in children with autismIon Anghelescu, Michael Dettling
Lancet (London, England)|December 9, 2014
Psychotropics and risk of violent crimeMichael Dettling, Ion Anghelescu
The New England Journal of Medicine|May 23, 2014
Pregabalin versus pramipexole for restless legs syndromeIon Anghelescu, Michael Dettling
The New England Journal of Medicine|February 28, 2009
Subthalamic nucleus stimulation in severe obsessive-compulsive disorderMichael Dettling, Ion-George Anghelescu
The New England Journal of Medicine|January 20, 2006
Antipsychotic drugs and schizophreniaMichael Dettling, Ion-George Anghelescu
Pharmacogenomics|August 7, 2008
Clozapine-induced agranulocytosis and its genetic determinantsCarolin Opgen-Rhein, Michael Dettling
Pageof 7